---
trial_id: 961
discovery_date: 2022-06-20 15:00:57.420754
date: 2022-06-20 15:00:57.420754
title: "An Open-label, Multi-center Rollover Protocol for Continued Characterization of Safety and Tolerability for Subjects Who Have Participated in a Novartis-sponsored Spartalizumab Study as Single Agent or in Combination With Other Study Treatments"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04058756'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
